查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855799

2025年人工智慧臨床試驗方案可行性工具全球市場報告

Artificial Intelligence Clinical Trial Protocol Feasibility Tool Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工智慧臨床試驗方案可行性工具的市場規模呈指數級成長，從2024年的6.5億美元成長到2025年的8.3億美元，複合年成長率達27.5%。預測期內的成長主要受以下因素驅動：臨床試驗通訊協定日益複雜、臨床試驗資料量不斷增加、傳統臨床試驗成本上升、數位醫療記錄的普及以及對以患者為中心的臨床試驗的日益重視。

預計未來幾年，人工智慧臨床試驗方案可行性工具市場將呈指數級成長，到2029年市場規模將達到21.7億美元，複合年成長率（CAGR）為27.1%。預測期內的成長主要受以下因素驅動：對個人化醫療試驗的需求不斷成長、分散式臨床試驗的日益普及、自然語言處理技術的廣泛應用、對試驗中患者多樣性的日益重視，以及臨床實驗可行性監測的重要性日益凸顯。預測期內的關鍵趨勢包括：用於最佳化試驗中心選擇的自適應演算法的開發、基因組數據的整合以實現精準的臨床實驗通訊協定、自動化臨床實驗成本和持續時間預測的創新、用於提高患者多樣性的工具的開發，以及多來源真實世界證據的整合以實現準確的可行性評估。

人工智慧臨床試驗方案可行性工具是一種軟體解決方案，它利用人工智慧演算法分析歷史臨床數據、患者族群和試驗設計參數，以評估提案臨床試驗的可行性。其主要目標是透過預測患者招募的可能性、識別通訊協定風險和最佳化臨床試驗設計，來減少臨床試驗的延誤並提高成功率。

人工智慧臨床試驗方案可行性工具的關鍵組成部分是軟體和服務。軟體包括利用人工智慧評估臨床試驗通訊協定、預測患者招募、識別風險並最佳化研究設計以提高試驗效率的數位平台。這些解決方案可透過雲端基礎或本機部署系統進行部署。應用領域包括方案設計、研究中心選擇、病患招募、風險評估等與臨床試驗相關的功能。主要最終用戶包括製藥和生物技術公司、委外研發機構(CRO)、學術和研究機構以及相關組織。

美國在2025年春季突然提高關稅，由此引發的貿易摩擦對醫療保健產業造成了嚴重衝擊，尤其對關鍵醫療設備、診斷試劑和藥品的供應造成了嚴重影響。醫院和醫療機構面臨進口手術器械、影像設備以及注射器、導管等耗材成本不斷上漲的困境。這些成本的增加加劇了醫療預算的緊張，導致一些醫療機構必須推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅也阻礙了必需藥品和醫療設備的生產，造成供應鏈瓶頸。為了應對這項挑戰，醫療產業正在積極調整籌資策略，盡可能地促進本地生產，並呼籲對緊急醫療產品實施關稅豁免。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，該系列報告提供人工智慧臨床試驗方案可行性工具市場統計數據，包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢和商業機會，以及在人工智慧臨床試驗方案工具行業取得成功所需的數據。本人工智慧臨床試驗方案可行性工具市場研究報告提供您所需的一切資訊，並對該行業的現狀和未來發展趨勢進行詳細分析。

精準醫療日益受到重視，預計將推動人工智慧臨床試驗方案可行性工具市場的成長。精準醫療是一種客製化的醫療保健方法，它利用患者的基因譜、環境暴露和生活方式來制定更有效、更具針對性的治療策略。基因序列測定和生物標記發現技術的進步使得早期檢測和高度標靶治療成為可能，加速了這一趨勢。基於人工智慧的臨床試驗方案可行性工具在精準醫療中發揮關鍵作用，它們能夠實現數據驅動的試驗設計，並加強試驗方案與特定患者亞群的匹配。這些工具透過預測患者招募成功率、試驗進度和潛在風險來提高臨床試驗效率，最終提高研究結果的準確性和有效性。例如，2024年3月，總部位於澳洲的生物技術公司諾沃泰克（Novotec）報告稱，2023年美國食品藥物管理局）核准的217種癌症藥物中，43%是精準療法。此外，其中78種治療方法採用了基於DNA或次世代定序儀的生物標記。因此，對精準醫療的日益重視極大地促進了人工智慧臨床試驗方案可行性工具市場的擴張。

為了提高方案的準確性並最大限度地減少臨床研究的延誤，該市場的主要企業正優先開發先進的解決方案，例如基於預測分析的試驗規劃工具。基於預測分析的臨床試驗規劃利用歷史數據和即時數據來評估試驗的可行性、預測成本和進度，並識別營運風險。這些工具透過減少對人工流程的依賴並支持試驗期間的適應性反應，從而增強試驗的設計和執行。例如，總部位於美國的臨床智慧公司 Lokavant Incorporated 於 2024 年 6 月推出了 Spectrum，這是第一個旨在支援整個臨床試驗生命週期可行性規劃的人工智慧平台。該平台整合了即時臨床試驗數據，並支援持續的預測、風險評估和入組方案評估。透過提供對預計進度、支出和招募結果的準確預測，Spectrum 支援及時、數據驅動的決策，幫助試驗團隊提高效率並減少代價高昂的延誤。

2025年3月，總部位於美國的醫療科技公司Tempus AI Incorporated收購了Deep 6 AI，具體金額未揭露。此舉旨在提高病患招募效率，擴大真實世界臨床數據的取得途徑，並推動人工智慧在臨床試驗配對和精準醫療領域的應用。 Deep 6 AI是一家總部位於美國的科技公司，專注於開發用於評估臨床試驗通訊協定可行性的人工智慧工具。

人工智慧臨床試驗方案可行性工具市場包括營業單位透過病患招募分析、中心選擇最佳化、方案設計可行性、風險評估與緩解以及資料整合與分析服務所產生的收入。市場價值包括服務供應商銷售的或包含在其服務產品中的相關商品的價值。僅包括在營業單位之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人工智慧臨床試驗方案可行性工具：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球人工智慧臨床試驗方案可行性工具市場：成長率分析
  • 全球人工智慧臨床試驗方案可行性工具市場表現：規模與成長，2019-2024年
  • 全球人工智慧臨床試驗方案可行性工具市場預測：規模與成長，2024-2029年，2034年預測
  • 全球人工智慧臨床試驗方案可行性工具：潛在市場規模 (TAM)

第6章 市場細分

  • 全球人工智慧臨床試驗方案可行性工具市場：按組件分類，實際值和預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 軟體
  • 服務
  • 全球人工智慧臨床試驗方案可行性工具市場：按部署模式、性能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 雲端基礎的
  • 本地部署
  • 全球人工智慧臨床試驗方案可行性工具市場：按應用、實際結果和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 通訊協定設計
  • 位置選擇
  • 病患招募
  • 風險評估
  • 其他用途
  • 全球人工智慧臨床試驗方案可行性工具市場：依最終用戶分類，實際值和預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 製藥和生物技術公司
  • 研究合約組織
  • 學術研究機構
  • 其他最終用戶
  • 全球人工智慧臨床試驗方案可行性工具市場：按軟體、類型、實際值和預測值細分，2019-2024年、2024-2029年預測值、2034年預測值
  • 預測分析
  • 機器學習
  • 自然語言處理
  • 資料整合
  • 全球人工智慧臨床試驗方案可行性工具市場：按服務、類型、實際值和預測值細分，2019-2024年、2024-2029年預測值、2034年預測值
  • 諮詢
  • 執行
  • 培訓和支持
  • 託管服務

第7章 區域和國家分析

  • 全球人工智慧臨床試驗方案可行性工具市場：區域分析、預測及成長，2019-2024年、2024-2029年預測、2034年預測
  • 全球人工智慧臨床試驗方案可行性工具市場：按國家/地區分類，實際結果和預測，2019-2024 年、2024-2029 年預測、2034 年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 人工智慧臨床試驗方案可行性工具市場：競爭格局
  • 人工智慧臨床試驗方案可行性工具市場：公司簡介
    • IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • SAS Institute Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Veeva Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Tempus AI Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Cytel Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • ArisGlobal LLC.
  • Saama Technologies Inc.
  • Norstella
  • ConcertAI
  • Komodo Health Inc.
  • H1 Inc.
  • TriNetX Inc.
  • ObjectiveHealth LLC
  • Lokavant Inc.
  • Inato Inc.
  • Clinerion Ltd.
  • Faro Health Inc.
  • Lantern Pharma Inc.
  • Ryght AI
  • BEKHealth Corporation

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年人工智慧臨床試驗方案可行性工具市場：提供新機會的國家
  • 人工智慧臨床試驗方案可行性工具市場展望（2029）：新興細分市場機會
  • 2029年人工智慧臨床試驗方案可行性工具市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38448

An artificial intelligence clinical trial protocol feasibility tool is a software solution that leverages AI algorithms to analyze historical clinical data, patient populations, and trial design parameters to evaluate the feasibility of a proposed clinical trial. Its main purpose is to predict patient recruitment potential, identify protocol risks, and optimize trial design, helping reduce delays and improve trial success rates.

The primary components of the artificial intelligence clinical trial protocol feasibility tool are software and services. Software includes digital platforms that use AI to assess clinical trial protocols, predict patient recruitment, identify risks, and optimize trial design for more efficient studies. These solutions are deployed through cloud-based or on-premises systems. Applications include protocol design, site selection, patient recruitment, risk assessment, and other trial-related functions. Key end-users include pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and research institutes, and related organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence clinical trial protocol feasibility tool market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence clinical trial protocol feasibility tool market statistics, including artificial intelligence clinical trial protocol feasibility tool industry global market size, regional shares, competitors with a artificial intelligence clinical trial protocol feasibility tool market share, detailed artificial intelligence clinical trial protocol feasibility tool market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence clinical trial protocol feasibility tool industry. This artificial intelligence clinical trial protocol feasibility tool market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence clinical trial protocol feasibility tool market size has grown exponentially in recent years. It will grow from $0.65 billion in 2024 to $0.83 billion in 2025 at a compound annual growth rate (CAGR) of 27.5%. The growth in the historic period is attributed to the increasing complexity of clinical trial protocols, growing volume of clinical trial data, rising costs of traditional trials, increasing adoption of digital health records, and greater focus on patient-centric trials.

The artificial intelligence clinical trial protocol feasibility tool market size is expected to see exponential growth in the next few years. It will grow to $2.17 billion in 2029 at a compound annual growth rate (CAGR) of 27.1%. The growth in the forecast period is driven by rising demand for personalized medicine trials, increased adoption of decentralized clinical trials, growing use of natural language processing, emphasis on patient diversity in trials, and the growing importance of real-time feasibility monitoring. Key trends in the forecast period include the development of adaptive algorithms for site selection optimization, integration of genomic data to enable precision trial protocols, innovation in automated trial cost and timeline estimation, creation of tools to enhance patient diversity, and integration of multi-source real-world evidence for accurate feasibility assessments.

The increasing focus on precision medicine is anticipated to support the growth of the artificial intelligence clinical trial protocol feasibility tool market. Precision medicine is a customized approach to healthcare that utilizes a patient's genetic profile, environmental exposure, and lifestyle to develop more effective and tailored treatment strategies. This emphasis is accelerating due to ongoing advancements in genomic sequencing and biomarker discovery, which allow for earlier detection and highly targeted therapies. Artificial intelligence-based clinical trial protocol feasibility tools play a critical role in precision medicine by enabling data-driven trial design and enhancing the alignment of study protocols with specific patient subgroups. These tools improve clinical trial efficiency by forecasting patient recruitment success, timelines, and potential risks, ultimately increasing the accuracy and effectiveness of research outcomes. For example, in March 2024, Novotech, a biotechnology company based in Australia, reported that in 2023, forty-three percent of the two hundred seventeen oncology therapies approved by the Food and Drug Administration in the United States were precision treatments. Additionally, seventy-eight of these therapies utilized DNA-based or next-generation sequencing biomarkers. Therefore, the growing emphasis on precision medicine is contributing significantly to the expansion of the artificial intelligence clinical trial protocol feasibility tool market.

Leading companies in this market are prioritizing the development of advanced solutions, such as trial planning tools powered by predictive analytics, to improve protocol accuracy and minimize delays in clinical research. Predictive analytics-driven trial planning refers to the use of historical and real-time data to assess study feasibility, forecast costs and timelines, and identify operational risks. These tools enhance trial design and execution by reducing reliance on manual processes and enabling adaptive responses during the study. For instance, in June 2024, Lokavant Incorporated, a clinical intelligence firm based in the United States, introduced Spectrum, the first artificial intelligence platform designed to support feasibility planning throughout the full clinical trial lifecycle. This platform integrates live clinical trial data and enables continuous forecasting, risk assessment, and enrollment scenario evaluation. Spectrum supports timely, data-informed decision-making by providing accurate estimates of projected timelines, expenditures, and recruitment outcomes, helping study teams improve efficiency and reduce costly delays.

In March 2025, Tempus AI Incorporated, a health technology company based in the United States, completed the acquisition of Deep 6 AI for an undisclosed amount. This strategic move aims to improve patient recruitment efficiency, broaden access to real-world clinical data, and advance the application of artificial intelligence in clinical trial matching and precision medicine. Deep 6 AI is a United States-based technology company that specializes in artificial intelligence tools for evaluating clinical trial protocol feasibility.

Major players in the artificial intelligence clinical trial protocol feasibility tool market are IQVIA Holdings Inc., SAS Institute Inc., Veeva Systems Inc., Tempus AI Inc., Cytel Inc., ArisGlobal LLC., Saama Technologies Inc., Norstella, ConcertAI, Komodo Health Inc., H1 Inc., TriNetX Inc., ObjectiveHealth LLC, Lokavant Inc., Inato Inc., Clinerion Ltd., Faro Health Inc., Lantern Pharma Inc., Ryght AI, and BEKHealth Corporation.

North America was the largest region in the artificial intelligence clinical trial protocol feasibility tool market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence clinical trial protocol feasibility tool report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence clinical trial protocol feasibility tool market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence clinical trial protocol feasibility tool market includes revenues earned by entities through patient recruitment analysis, site selection optimization, protocol design feasibility, risk assessment and mitigation, and data integration and analytics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence Clinical Trial Protocol Feasibility Tool Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence clinical trial protocol feasibility tool market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence clinical trial protocol feasibility tool ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence clinical trial protocol feasibility tool market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Services
  • 2) By Deployment Mode: Cloud-Based; On-Premises
  • 3) By Application: Protocol Design; Site Selection; Patient Recruitment; Risk Assessment; Other Applications
  • 4) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Software: Predictive Analytics; Machine Learning; Natural Language Processing; Data Integration
  • 2) By Services: Consulting; Implementation; Training And Support; Managed Services
  • Companies Mentioned: IQVIA Holdings Inc.; SAS Institute Inc.; Veeva Systems Inc.; Tempus AI Inc.; Cytel Inc.; ArisGlobal LLC.; Saama Technologies Inc.; Norstella; ConcertAI; Komodo Health Inc.; H1 Inc.; TriNetX Inc.; ObjectiveHealth LLC; Lokavant Inc.; Inato Inc.; Clinerion Ltd.; Faro Health Inc.; Lantern Pharma Inc.; Ryght AI; BEKHealth Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Characteristics

3. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Trends And Strategies

4. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Total Addressable Market (TAM)

6. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Segmentation

  • 6.1. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Services
  • 6.2. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloud-Based
  • On-Premises
  • 6.3. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Protocol Design
  • Site Selection
  • Patient Recruitment
  • Risk Assessment
  • Other Applications
  • 6.4. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations
  • Academic And Research Institutes
  • Other End-Users
  • 6.5. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Analytics
  • Machine Learning
  • Natural Language Processing
  • Data Integration
  • 6.6. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting
  • Implementation
  • Training And Support
  • Managed Services

7. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 8.1. Asia-Pacific Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 9.1. China Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 9.2. China Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 10.1. India Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 11.1. Japan Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 11.2. Japan Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 12.1. Australia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 13.1. Indonesia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 14.1. South Korea Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 14.2. South Korea Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 15.1. Western Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 15.2. Western Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 16.1. UK Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 17.1. Germany Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 18.1. France Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 19.1. Italy Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 20.1. Spain Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 21.1. Eastern Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 21.2. Eastern Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 22.1. Russia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 23.1. North America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 23.2. North America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 24.1. USA Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 24.2. USA Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 25.1. Canada Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 25.2. Canada Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 26.1. South America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 26.2. South America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 27.1. Brazil Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 28.1. Middle East Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 28.2. Middle East Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

  • 29.1. Africa Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview
  • 29.2. Africa Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Competitive Landscape
  • 30.2. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Company Profiles
    • 30.2.1. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. SAS Institute Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Veeva Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Tempus AI Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Cytel Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Other Major And Innovative Companies

  • 31.1. ArisGlobal LLC.
  • 31.2. Saama Technologies Inc.
  • 31.3. Norstella
  • 31.4. ConcertAI
  • 31.5. Komodo Health Inc.
  • 31.6. H1 Inc.
  • 31.7. TriNetX Inc.
  • 31.8. ObjectiveHealth LLC
  • 31.9. Lokavant Inc.
  • 31.10. Inato Inc.
  • 31.11. Clinerion Ltd.
  • 31.12. Faro Health Inc.
  • 31.13. Lantern Pharma Inc.
  • 31.14. Ryght AI
  • 31.15. BEKHealth Corporation

32. Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

34. Recent Developments In The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

35. Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer